Need professional-grade analysis? Visit stockanalysis.com
$34.66B
26.76
1,458
1.73%
Price Chart
Risk-Adjusted Performance
Imeik Technology Development Co (300896) Price Performance
Imeik Technology Development Co (300896) trades on SHE in CNY. The company is classified in the Healthcare sector under the Medical Instruments & Supplies industry. The stock currently trades at CNY114.55, down 1.06% from the previous close.
Over the past year, 300896 has traded between a low of CNY112.46 and a high of CNY199.67. The stock has lost 33.5% over this period. It is currently 42.6% below its 52-week high.
Imeik Technology Development Co has a market capitalization of $34.66B, with a price-to-earnings ratio of 26.76 and a dividend yield of 1.73%.
About Imeik Technology Development Co
Imeik Technology Development Co.,Ltd. engages in the research and development, and transformation of biomedical materials and biopharmaceutical products in China. The company offers aesthetic medicine products, such as cross-linked sodium hyaluronate gel with PLLA-b-PEG microsphere; poly facial implant thread; medical sodium hyaluronate-hydroxypropyl methylcellulose gel; sodium hyaluronate composite solution for injection; modified sodium hyaluronate gel for injection; medical PVA gel ball-sodium hyaluronate-hydroxypropyl methylcellulose gel; and skin care products. It serves medical aesthetic institutions. The company was incorporated in 2004 and is headquartered in Beijing, China.
Compare Imeik Technology Development Co
Side-by-side comparison against top Healthcare peers.
Company Info
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Exchange
- SHE
- Currency
- CNY
- Country
- China
Financial Metrics
- Revenue (TTM)
- $2.45B
- EBITDA
- $1.36B
- Profit Margin
- 52.64%
- EPS (TTM)
- 4.28
- Book Value
- 25.16
Technical Indicators
- 52 Week High
- CN¥201.54
- 52 Week Low
- CN¥112.30
- 50 Day MA
- CN¥134.01
- 200 Day MA
- CN¥158.06
- Beta
- 0.97
Valuation
- Trailing P/E
- 26.76
- Forward P/E
- 23.58
- Price/Sales
- 14.13
- Price/Book
- 4.62
- Enterprise Value
- $31.91B